C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/867 (2006.01) C07K 14/15 (2006.01) C07K 14/16 (2006.01) C12N 7/04 (2006.01) A61K 39/00 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2117607
Novel vectors are capable of producing MPMV (Mason-Pfizer Monkey Virus) proteins but not of packaging MPMV RNA, and the information about the packaging signal in MPMV and HIV can be used to create MPMV and HIV vectors that are capable of transferring foreign genes, e.g. for use in gene therapy.
Hunter Eric
Lever Andrew M. L.
Hunter Eric
Lever Andrew M. L.
Ridout & Maybee Llp
Syngenix Limited
LandOfFree
Defective packaging non-oncoviral vectors based on mpmv and hiv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Defective packaging non-oncoviral vectors based on mpmv and hiv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Defective packaging non-oncoviral vectors based on mpmv and hiv will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1578976